SNEMX
Price
$28.69
Change
-$0.14 (-0.49%)
Updated
Feb 21 closing price
Net Assets
1.1B
VEMIX
Price
$29.23
Change
+$0.04 (+0.14%)
Updated
Feb 21 closing price
Net Assets
109.55B
Ad is loading...

SNEMX vs VEMIX

Header iconSNEMX vs VEMIX Comparison
Open Charts SNEMX vs VEMIXBanner chart's image
AB Emerging Markets
Price$28.69
Change-$0.14 (-0.49%)
VolumeN/A
Net Assets1.1B
Vanguard Emerging Mkts Stock Idx Instl
Price$29.23
Change+$0.04 (+0.14%)
VolumeN/A
Net Assets109.55B
SNEMX vs VEMIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SNEMX vs. VEMIX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNEMX is a Buy and VEMIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 110B vs. SNEMX (1.1B). VEMIX pays higher dividends than SNEMX: VEMIX (3.46) vs SNEMX (1.56). SNEMX was incepted earlier than VEMIX: SNEMX (29 years) vs VEMIX (25 years). SNEMX is a more actively managed with annual turnover of: 58.00 vs. VEMIX (5.00). SNEMX has a lower initial minimum investment than VEMIX: SNEMX (5000) vs VEMIX (5000000). VEMIX annual gain was more profitable for investors over the last year : 13.44 vs. SNEMX (12.32). VEMIX return over 5 years is better than : 17.83 vs. SNEMX (11.56).
SNEMXVEMIXSNEMX / VEMIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years25 years-
Gain YTD6.7784.399154%
Front LoadN/AN/A-
Min. Initial Investment500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.1B110B1%
Annual Yield % from dividends1.563.4645%
Returns for 1 year12.3213.4492%
Returns for 3 years1.452.0271%
Returns for 5 years11.5617.8365%
Returns for 10 years17.3131.5155%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SR75.071.13
+1.53%
Spire
LH249.850.68
+0.27%
Laboratory Corp
CAPL22.87-0.38
-1.63%
CrossAmerica Partners LP
EGAN5.09-0.10
-1.93%
eGain Corp
NEUP4.88-0.17
-3.37%
Neuphoria Therapeutics Inc